“…33,45 Second, we have observed, along with others, 19 that children across all IBD types differ significantly in their ability to produce a serum CRP response, even in the presence of overt clinical disease. Finally, recent evidence has suggested that adult patients with IBD with a high baseline CRP level at induction demonstrate a better primary response to biological therapies, with early normalization of CRP levels correlating with sustained long-term response 21,47 ; however, these results are variable. 4 Third, regarding cardiovascular risk and systemic lupus erythematosus, studies have suggested that failure to respond appropriately to inflammation with a rise in serum CRP may be a factor in disease pathogenesis.…”